Skip to content

Volume Targeted Mask Ventilation Versus Pressure Ventilation in Preterm Infants

Volume Targeted Mask Ventilation Versus Pressure Ventilation in Preterm Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05144724
Acronym
VOLT
Enrollment
52
Registered
2021-12-03
Start date
2024-10-01
Completion date
2025-12-17
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Respiratory Distress

Brief summary

This is a pilot trial to assess the feasibility of volume Targeted Ventilation in the Delivery Room. Preterm infants will be randomized to pressure guided or volume targeted ventilation during respiratory support in the delivery room

Interventions

Positive pressure ventilation will be provided using a set tidal volume

PROCEDUREPressure targeted ventilation

Positive pressure ventilation will be provided using a set peak inflation pressure

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
0 Minutes to 1 Minutes
Healthy volunteers
No

Inclusion criteria

* Born between 23+0/7 to 28+6/7 weeks' gestation * Considered suitable for full resuscitation, i.e., no parental request or antenatal decision to forego resuscitation * Informed parental consent

Exclusion criteria

* Major congenital or chromosomal malformation * Conditions that might have an adverse effect on breathing or ventilation (e.g., high risk for lung hypoplasia, congenital diaphragmatic hernia) * Congenital heart disease requiring intervention in the neonatal period * Hydrops requiring intervention in the neonatal period * Neonatal resuscitation initiated before NICU team arrival * Infants who are born outside of study center and transported to center after delivery

Design outcomes

Primary

MeasureTime frameDescription
Percentage of of eligible participants (=infants requiring PPV) who have the intervention performed correctly without protocol deviation (=cross over to control group when randomized to VTV-group)Through study completion (total 18 months)Percentage of Participants who have received allocated treatment

Secondary

MeasureTime frameDescription
Number of participants with mortalityup to 6 months of NICU admissionInfants who died during NICU admission - all-cause in-hospital
Number of participants with severe brain injury on cranial ultrasoundup to 6 months of NICU admissionSevere grade 3 and 4 intraventricular or intraparenchymal hemorrhage according to Papile, periventricular leukomalacia, or ventriculomegaly based on neuroimaging studies (timing and frequency of imaging based on local site practices)
Number of participants with severe retinopathy of prematurity (stage 3 or higher)up to 6 months of NICU admissionDefined in the International Classification of ROP, and/or ROP treated with laser, cryotherapy, or intraocular injection therap
Number of participants with bronchopulmonary dysplasia at 36 weeks corrected ageAt 36 weeks corrected ageDefined as receiving any supplemental oxygen or any form of respiratory support (including invasive mechanical ventilation, non-invasive ventilation with continuous positive airway pressure, nasal intermittent positive pressure ventilation, or high-flow nasal canula)
Number of participants with Bronchopulmonary dysplasia at 40 weeks corrected ageAt 40 weeks corrected ageDefined as receiving any supplemental oxygen or any form of respiratory support (including invasive mechanical ventilation, non-invasive ventilation with continuous positive airway pressure, nasal intermittent positive pressure ventilation, or high-flow nasal canula)
Total duration of mechanical ventilation via an endotracheal tube in daysDays during NICU admission (up to 6 months)Count of days in were an endotracheal tube was placed and the infant was mechanical ventilation
Number of participants discharge home on oxygenAt time of NICU discharge (with 6 moths from birth)Infants being discharged home with oxygen
Duration of any respiratory support in daysDays during NICU admission (up to 6 months)Defined as invasive mechanical ventilation, non-invasive ventilation with continuous positive airway pressure, nasal intermittent positive pressure ventilation, or non-invasive neural assist ventilation or non-invasive high frequency ventilation, or high-flow nasal cannula) in days
Number of participants with necrotizing enterocolitisup to 6 months of NICU admissionDefined as modified Bell's criteria stage 2 or greater
Duration of positive pressure ventilation at birth in dayswithin the first 10 min after birthInfants who received positive pressure ventilation in the delivery room at birth
Duration of supplemental oxygen in daysDays during NICU admission (up to 6 months)Count of days in were the infant received supplemental oxygen
Length of hospital stay in daysNumber of days from birth to discharge (up to 6 months)Defined as number of days from birth to discharge
Rate of intubation in the delivery roomwithin 60min after birthInfants who were intubated in the delivery room at birth
Rate of chest compression in the delivery roomwithin 60min after birthInfants who received chest compression in the delivery room at birth
Rate of pneumothoraxup to 6 months of NICU admissionDiagnosed by chest x-ray or lung ultrasound) and interventions (e.g., needle drainage or chest drain)

Other

MeasureTime frameDescription
Resuscitators subjective workload performing mask ventilationwithin the first 10 min after birthEs evaluated by Surgery Task Load Index (SURG-TLX)-questionnaire.
Resuscitators qualitative feedback on using VTV-PPV in the delivery roomwithin the first 10 min after birthProvided through free text responses

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026